[{"_id":"551f89b631cae9239deb1ef6","会社名":"エスエス製薬(株)【4537】","証券コード":"4537","決算期":"2009年12月期","会計方式":"日本方式","決算発表日":"2010年2月10日","決算月数":"12か月","売上高":"47,505百万円","営業利益":"3,948百万円","経常利益":"4,216百万円","当期利益":"1,792百万円","EPS（一株当たり利益）":"15.47円","調整一株当たり利益":"15.36円","BPS（一株当たり純資産）":"497.48円","総資産":"69,629百万円","自己資本":"57,611百万円","資本金":"10,172百万円","有利子負債":"495百万円","自己資本比率":"82.7%","ROA（総資産利益率）":"2.37%","ROE（自己資本利益率）":"3.11%","総資産経常利益率":"5.58%","__v":0,"日付":"2015-04-04T06:50:30.846Z"},{"_id":"551f89b631cae9239deb1ef7","会社名":"エスエス製薬(株)【4537】","証券コード":"4537","決算期":"2008年12月期","会計方式":"日本方式","決算発表日":"2009年2月5日","決算月数":"12か月","売上高":"48,557百万円","営業利益":"3,219百万円","経常利益":"2,985百万円","当期利益":"790百万円","EPS（一株当たり利益）":"6.50円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"497.57円","総資産":"81,496百万円","自己資本":"57,652百万円","資本金":"10,172百万円","有利子負債":"10,328百万円","自己資本比率":"70.7%","ROA（総資産利益率）":"0.92%","ROE（自己資本利益率）":"1.32%","総資産経常利益率":"3.46%","__v":0,"日付":"2015-04-04T06:50:30.846Z"},{"_id":"551f89b631cae9239deb1ef8","会社名":"エスエス製薬(株)【4537】","証券コード":"4537","決算期":"2007年12月期","会計方式":"日本方式","決算発表日":"2008年2月7日","決算月数":"9か月","売上高":"38,171百万円","営業利益":"2,387百万円","経常利益":"2,519百万円","当期利益":"1,256百万円","EPS（一株当たり利益）":"10.28円","調整一株当たり利益":"10.04円","BPS（一株当たり純資産）":"510.06円","総資産":"90,817百万円","自己資本":"62,326百万円","資本金":"10,172百万円","有利子負債":"13,017百万円","自己資本比率":"68.6%","ROA（総資産利益率）":"---","ROE（自己資本利益率）":"---","総資産経常利益率":"---","__v":0,"日付":"2015-04-04T06:50:30.847Z"}]{"_id":"551f89b631cae9239deb1ef9","会社名":"エスエス製薬(株)【4537】","証券コード":"4537","決算期":"2009年12月期","会計方式":"日本方式","決算発表日":"2010年2月10日","決算月数":"12か月","売上高":"47,505百万円","営業利益":"3,948百万円","経常利益":"4,216百万円","当期利益":"1,792百万円","EPS（一株当たり利益）":"15.47円","調整一株当たり利益":"15.36円","BPS（一株当たり純資産）":"497.48円","総資産":"69,629百万円","自己資本":"57,611百万円","資本金":"10,172百万円","有利子負債":"495百万円","自己資本比率":"82.7%","ROA（総資産利益率）":"2.37%","ROE（自己資本利益率）":"3.11%","総資産経常利益率":"5.58%","__v":0,"日付":"2015-04-04T06:50:30.850Z"},{"_id":"551f89b631cae9239deb1efa","会社名":"エスエス製薬(株)【4537】","証券コード":"4537","決算期":"2008年12月期","会計方式":"日本方式","決算発表日":"2009年2月5日","決算月数":"12か月","売上高":"48,557百万円","営業利益":"3,219百万円","経常利益":"2,985百万円","当期利益":"790百万円","EPS（一株当たり利益）":"6.50円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"497.57円","総資産":"81,496百万円","自己資本":"57,652百万円","資本金":"10,172百万円","有利子負債":"10,328百万円","自己資本比率":"70.7%","ROA（総資産利益率）":"0.92%","ROE（自己資本利益率）":"1.32%","総資産経常利益率":"3.46%","__v":0,"日付":"2015-04-04T06:50:30.850Z"},{"_id":"551f89b631cae9239deb1efb","会社名":"エスエス製薬(株)【4537】","証券コード":"4537","決算期":"2007年12月期","会計方式":"日本方式","決算発表日":"2008年2月7日","決算月数":"9か月","売上高":"38,171百万円","営業利益":"2,387百万円","経常利益":"2,519百万円","当期利益":"1,256百万円","EPS（一株当たり利益）":"10.28円","調整一株当たり利益":"10.04円","BPS（一株当たり純資産）":"510.06円","総資産":"90,817百万円","自己資本":"62,326百万円","資本金":"10,172百万円","有利子負債":"13,017百万円","自己資本比率":"68.6%","ROA（総資産利益率）":"---","ROE（自己資本利益率）":"---","総資産経常利益率":"---","__v":0,"日付":"2015-04-04T06:50:30.851Z"}]